AMD/Retina Edition: Top Headlines for Week of August 29, 2022
- Author
- Healio
- Published
- Wed 31 Aug 2022
- Episode Link
- http://sites.libsyn.com/408806/amdretina-edition-top-headlines-for-the-week-of-august-29-2022
In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more.
Association found between macular retinal nerve fiber layer thickness, cognitive decline
FDA approves Cimerli as interchangeable biosimilar to Lucentis
Black patients have higher risk for advanced visual field loss after glaucoma diagnosis
iStent infinite cleared by FDA
Alcon to acquire Aerie Pharmaceuticals
References:
Kang JH, et al. Transl Vis Sci Technol. 2022;doi:10.1167/tvst.11.7.21.
Kim HM, et al. JAMA Ophthalmol. 2022;doi:10.1001/jamaophthalmol.2022.1563.
